Department of Radiology, CTO Hospital, Azienda Ospedaliera dei Colli, Naples, Italy.
Department of Neuroradiology, Ospedale del Mare, Naples, Italy.
Semin Ultrasound CT MR. 2023 Jun;44(3):126-135. doi: 10.1053/j.sult.2023.02.003. Epub 2023 Mar 1.
Primary central nervous system lymphoma (PCNSL) is a rare form of extranodal non-Hodgkin's lymphoma that accounts for 1%-5% of all central nervous system tumors. Contrast-enhanced MR is the imaging technique of choice. PCNLs have a predilection for the periventricular and superficial regions, often abutting the ventricular or meningeal surfaces. Although PCNLs may have characteristic imaging features on conventional MRI, none of these will unequivocally differentiate PCNSLs from other brain lesions. Diffusion restriction, relative hypoperfusion, increased choline/creatinine, decrease of N-acetyl aspartate (NAA) peak as well as the presence of lactate and lipid peaks are consistent advanced imaging findings in CNS lymphoma that may help in the differentiation of Primary central nervous system lymphomas (PCNSLs) from other malignancies. Furthermore, advanced imaging techniques will presumably play an important role in the planning of new targeted therapies, for prognostication, and for the monitoring of treatment response in the future.
原发性中枢神经系统淋巴瘤(PCNSL)是一种罕见的结外非霍奇金淋巴瘤,占所有中枢神经系统肿瘤的 1%-5%。增强磁共振成像(MRI)是首选的影像学检查方法。PCNSL 倾向于发生在脑室周围和表浅部位,常与脑室或脑膜表面相邻。尽管 PCNSL 在常规 MRI 上可能具有特征性影像学表现,但没有任何一种表现可以明确将其与其他脑部病变区分开来。弥散受限、相对低灌注、胆碱/肌酐增加、N-乙酰天门冬氨酸(NAA)峰降低以及乳酸峰和脂质峰的出现,是中枢神经系统淋巴瘤的一致的高级影像学表现,有助于将原发性中枢神经系统淋巴瘤(PCNSL)与其他恶性肿瘤区分开来。此外,高级影像学技术可能在未来新的靶向治疗方案的制定、预后评估以及治疗反应的监测方面发挥重要作用。